DK112391A - Fremgangsmaade og praeparat til tidlig paavisning af insulinafhaengig diabetes mellitus - Google Patents
Fremgangsmaade og praeparat til tidlig paavisning af insulinafhaengig diabetes mellitus Download PDFInfo
- Publication number
- DK112391A DK112391A DK112391A DK112391A DK112391A DK 112391 A DK112391 A DK 112391A DK 112391 A DK112391 A DK 112391A DK 112391 A DK112391 A DK 112391A DK 112391 A DK112391 A DK 112391A
- Authority
- DK
- Denmark
- Prior art keywords
- insulinable
- procedure
- preparation
- diabetes mellitus
- early determination
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6871—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an enzyme
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28363388A | 1988-12-13 | 1988-12-13 | |
| US42705189A | 1989-10-25 | 1989-10-25 | |
| PCT/US1989/005570 WO1990007117A1 (en) | 1988-12-13 | 1989-12-08 | Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK112391A true DK112391A (da) | 1991-06-12 |
| DK112391D0 DK112391D0 (da) | 1991-06-12 |
Family
ID=26962160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK911123A DK112391D0 (da) | 1988-12-13 | 1991-06-12 | Fremgangsmaade og praeparat til tidlig paavisning af insulinafhaengig diabetes mellitus |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0448635B1 (da) |
| KR (1) | KR910700459A (da) |
| AU (1) | AU4815890A (da) |
| CA (1) | CA2005300C (da) |
| DE (1) | DE68924354T2 (da) |
| DK (1) | DK112391D0 (da) |
| ES (1) | ES2077670T3 (da) |
| WO (1) | WO1990007117A1 (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5645998A (en) | 1988-12-13 | 1997-07-08 | University Of Florida Research Foundation | Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
| US5762937A (en) * | 1988-12-13 | 1998-06-09 | University Of Florida Research Foundation, Inc. | Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
| US6001360A (en) * | 1988-12-13 | 1999-12-14 | University Of Florida | Method and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| US5427940A (en) * | 1991-06-03 | 1995-06-27 | Board Of Regents, The University Of Texas System | Engineered cells producing insulin in response to glucose |
| ES2093714T3 (es) * | 1990-08-17 | 1997-01-01 | Univ Florida | Metodos y composiciones para la deteccion y el tratamiento precoces de la diabetes mellitus insulinodependiente. |
| JP2727377B2 (ja) | 1990-09-07 | 1998-03-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 糖尿病自己抗体の検出方法 |
| US5512447A (en) * | 1990-09-07 | 1996-04-30 | The Regents Of The University Of California | Methods for the diagnosis and treatment of diabetes |
| US6682906B1 (en) | 1990-09-21 | 2004-01-27 | The Regents Of The University Of California | Cloned glutamic acid decarboxylase |
| US5998366A (en) * | 1990-09-21 | 1999-12-07 | The Regents Of The University Of California | Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders |
| US5674978A (en) | 1990-09-21 | 1997-10-07 | The Regents Of The University Of California | Peptides derived from glutamic acid decarboxylase |
| AU8864791A (en) * | 1990-10-02 | 1992-04-28 | Trigen Incorporated | Antibodies and methods for diagnosis and treatment of diabetes |
| US5422339A (en) * | 1991-03-19 | 1995-06-06 | Joslin Diabetes Center, Inc. | Peptides having insulin autoantibody but not insulin receptor binding capacity |
| WO1992020811A2 (en) * | 1991-05-15 | 1992-11-26 | Zymogenetics, Inc. | Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
| US5407802A (en) * | 1991-12-26 | 1995-04-18 | Immulogic Pharmaceutical Corporation | Method of accessing the risks of developing type I diabetes |
| EP0627934A4 (en) * | 1992-02-27 | 1997-01-08 | Univ Leland Stanford Junior | EARLY ANTIGEN FOR AUTOIMMUNE DIABETE. |
| JPH07505719A (ja) * | 1992-04-14 | 1995-06-22 | デューク・ユニバーシティー | p53及びHSP70のコンプレックスを含む腫瘍の検出方法 |
| US5200318A (en) * | 1992-05-13 | 1993-04-06 | Miles Inc. | Diagnosis of IDDM with a panel of immunoreagents |
| DE4237244A1 (de) * | 1992-11-04 | 1994-05-05 | Elias Entwicklungslabor Fuer I | Verfahren zur Herstellung hochreiner humaner GAD-1- und GAD-2- Proteine |
| US5561049A (en) * | 1994-09-21 | 1996-10-01 | Behringwerke Ag | Method for detecting antibodies |
| IL112094A0 (en) * | 1994-12-21 | 1995-03-15 | Yeda Res & Dev | Novel peptides and pharmaceutical compositions comprising them |
| US6303325B1 (en) | 1998-05-29 | 2001-10-16 | Dade Behring Inc. | Method for detecting analytes |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0397798A4 (en) * | 1988-02-03 | 1991-10-30 | Xoma Corporation | Therapeutic use of anti-t cell immunotoxin for autoimmune diseases |
-
1989
- 1989-12-08 EP EP90901345A patent/EP0448635B1/en not_active Revoked
- 1989-12-08 WO PCT/US1989/005570 patent/WO1990007117A1/en not_active Ceased
- 1989-12-08 DE DE68924354T patent/DE68924354T2/de not_active Revoked
- 1989-12-08 AU AU48158/90A patent/AU4815890A/en not_active Abandoned
- 1989-12-08 ES ES90901345T patent/ES2077670T3/es not_active Expired - Lifetime
- 1989-12-08 KR KR1019900701752A patent/KR910700459A/ko not_active Withdrawn
- 1989-12-12 CA CA002005300A patent/CA2005300C/en not_active Expired - Lifetime
-
1991
- 1991-06-12 DK DK911123A patent/DK112391D0/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0448635B1 (en) | 1995-09-20 |
| DE68924354D1 (de) | 1995-10-26 |
| AU4815890A (en) | 1990-07-10 |
| WO1990007117A1 (en) | 1990-06-28 |
| DE68924354T2 (de) | 1996-02-22 |
| CA2005300A1 (en) | 1990-06-13 |
| EP0448635A1 (en) | 1991-10-02 |
| CA2005300C (en) | 2000-02-15 |
| DK112391D0 (da) | 1991-06-12 |
| ES2077670T3 (es) | 1995-12-01 |
| KR910700459A (ko) | 1991-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK112391D0 (da) | Fremgangsmaade og praeparat til tidlig paavisning af insulinafhaengig diabetes mellitus | |
| DK4191D0 (da) | Polymersammensaetning og fremgangsmaade til fremstilling af denne | |
| DK195987A (da) | Fremgangsmaade til fremstilling af en aniosotropt ledende elastomer og anvendelse af denne | |
| DK8787A (da) | Indolderivater og fremgangsmaade til fremstilling deraf | |
| DK3687D0 (da) | Polypeptider og fremgangsmaade til fremstilling deraf | |
| DK620487D0 (da) | Blodkarprotese og fremgangsmaade til fremstilling af denne | |
| DK159288D0 (da) | Saccharidblanding og fremgangsmaade til fremstilling deraf | |
| DK315484A (da) | Farmaceutisk praeparat, specielt til behandling af diabetes og fedme | |
| DK535687A (da) | Asbestfri friktionsmaterialer og fremgangsmaade til deres fremstilling | |
| DK64187D0 (da) | Enzym-foeler og fremgangsmaade til fremstilling af en saadan | |
| DK565288D0 (da) | Fremgangsmaade til fremstilling af triglycerider, anvendelse af saadanne triglycerider og en emulsion, der indeholder saadanne triglycerider | |
| DK355387A (da) | Overtraekspraeparat og fremgangsmaade til anvendelse deraf | |
| DK440288A (da) | Anvendelse af eicosapentaensyre og/eller docosahexaensyre til fremstilling af midler til behandling af diabetes mellitus | |
| DK549087D0 (da) | Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme | |
| DK114588A (da) | Sammensaetning og fremgangsmaade til immunologisk kastration og udboedning | |
| DK448887D0 (da) | Hidtil ukendt amylaseenzym og fremgangsmaade til fremstilling af samme | |
| DK362987A (da) | Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf | |
| DK192390D0 (da) | Fremgangsmaade til fremstilling af sukkerforbindelser | |
| DK0390762T3 (da) | Hidtil ukendte bronchospasmolytiske forbindelser og fremgangsmåde til fremstilling heraf | |
| DK221689A (da) | Naturstensplade og fremgangsmaade til fremstilling af naturstensplade | |
| DK660387D0 (da) | Maleimidgruppeholdige formstofblandinger og fremgangsmaade til fremstilling deraf | |
| DK436887A (da) | Fremgangsmaade til fremstilling af triazol-tetrahydrofuran-derivater og mellemprodukter til anvendelse herved | |
| DK129689A (da) | Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf | |
| DK508689A (da) | Organofluorider af tin og fremgangsmaade til fremstilling heraf | |
| DK15788D0 (da) | Fremgangsmaade og apparat til maaling af fuldblods koagulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |